HCV panel on Sept 19th during Congressional Black Caucus Foundation Annual Legislative Conference

 
 
Share this
 
 

Corporate Hepatitis Alliance (CHA)

Presents

“The Silent Epidemic”
Understanding hepatitis C (HCV) and the crisis among African American Communities

Thursday September 19th

4:00 PM to 5:30 PM

Walter E. Washington Convention Center – Room 140-A
801 Mount Vernon Place, NW * Washington, DC 20001

To register or for more information:: CHAInfo@CorpHepatitisAlliance.com

Please note: A registration fee is not required to attend this event only a conference badge is required to enter.

Please go to any registration table and ask for a conference badge to attend “The Silent Epidemic” Panel Discussion Room 140-A.

 

Panelists

Dr. John Ward, Director of the Division of Viral Hepatitis, NCHHSTP, CDC Dr. Charles Howell, Professor and Director of Hepatology Research, University of Maryland Dr. Stephen R. Lee, Executive Vice President & Chief Science Officer, OraSure Technologies, Inc. Ms. Barbara H. McGovern, MA, Associate Medical Director, AbbVie Pharmaceuticals Mr. Christopher H. Bates, MPA, Director, Department of HHS, Office of HIV/AIDS Policy (OHAP) Ms. Hadiyah Charles, MA, Hepatitis C Advocacy Manager, Harm Reduction Coalition

Guest Speaker

The Mayor Johnny Ford of Tuskegee, Alabama, B.A., MBA, Founder and the Director General of The World Conference of Mayors (WCM), President-emeritus and Founder of the National Conference of Black Mayors

This event is sponsored by AbbVie Pharmaceuticals • OraSure Technologies, Inc.

Corporate Hepatitis Alliance Participating Industry Partners;
AbbVie Pharmaceuticals • Achillion Pharmaceuticals • Alere, Inc. • Biotest Pharmaceuticals Corporation • Boehringer Ingelheim Pharmaceuticals, Inc. Bristol-Myers Squibb • Genentech • Gilead Sciences, Inc. • GlaxoSmithKline • Health & Medicine Council of Washington • Johnson & Johnson • Kadmon Pharmaceuticals • Merck & Co. • OraSure Technologies, Inc. • Vertex Pharmaceuticals